Загрузка...
Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors in patients with epidermal growth factor receptor gene mutation-positive lung cancer
Recent progress in the research on the molecular biology of lung cancer revealed that the clinical response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is associated with the presence of activating EGFR mutations. Three EGFR-TKIs, namely afatinib, erlotinib and gefit...
Сохранить в:
| Опубликовано в: : | Mol Clin Oncol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5244907/ https://ncbi.nlm.nih.gov/pubmed/28123721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.1099 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|